| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director | President, Cologuard
2 companies
Stenhouse Mark is a Director at PHAT with holdings across 2 companies. Recent SEC Form 4 filings include 0 buys and 3 sells.
Estimated insider holdings value: $2.0M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Apr 3, 2020 | EXAS Exact Sciences Corp | President, Cologuard | Sale+OE | 11,948 | $56.69 | $677,332.12 | -28.8% | |
| Feb 27, 2020 | EXAS Exact Sciences Corp | President, Cologuard | Sale+OE | 1,051 | $80.27 | $84,363.77 | -6.0% | |
| Apr 3, 2019 | EXAS Exact Sciences Corp | President, Cologuard | Sale+OE | 11,192 | $92.54 | $1,035,696.49 | -43.9% |